| Upcoming events on BLUEBIRD BIO, INC. |
|
| 05/05/21 | | Q1 2021 Earnings Release (Projected) |
| 08/04/21 | | Interim 2021 Earnings Release (Projected) |
| 11/03/21 | | Q3 2021 Earnings Release (Projected) |
| 02/23/22 | | FY 2021 Earnings Release (Projected) |
|
| Past events on BLUEBIRD BIO, INC. |
|
| 02/25/21 | 12:00pm | | Leerink Global Healthcare Conference |
| 02/23/21 | 04:05pm | | FY 2020 Earnings Release |
| 02/16/21 | 08:00am | | LentiGlobin Update Call |
| 01/11/21 | 02:50pm | | JP Morgan Healthcare Conference |
|
| Upcoming sector events for BLUEBIRD BIO, INC. |
|
|
| |
|
| Past sector events for BLUEBIRD BIO, INC. |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 6,16
6,27
-1,8% | 35,4
38,8
-8,7% | 54,6
43,0
27% | 44,7
43,4
2,9% | 251
259
-3,2% |
102
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -254
-248
-2,6% | -319
-283
-13% | -555
-559
0,68% | -797
-766
-4,1% | -604
-608
0,72% |
-803
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -264
-267
1,3% | -332
-298
-12% | -572
-573
0,09% | -815
-804
-1,3% | -623
-624
0,18% |
-798
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -264
-266
0,70% | -335
-300
-12% | -555
-562
1,1% | -790
-782
-1,0% | -618
-598
-3,3% |
-800
|
Net income
M $ |
Released
Forecast
Spread | -264
-266
0,77% | -336
-300
-12% | -556
-562
1,1% | -790
-781
-1,0% | -619
-599
-3,3% |
-800
|
EPS
$ |
Released
Forecast
Spread | -7,07
-7,10
0,38% | -7,71
-6,86
-12% | -10,7
-10,8
1,0% | -14,3
-14,1
-1,8% | -9,95
-9,94
-0,13% |
-11,7
| | Announcement Date | 02/22/2017 | 02/21/2018 | 02/21/2019 | 02/18/2020 | 02/23/2021 | |
|
|
|
| Quarterly results | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) |
Sales
M $ |
Released
Forecast
Spread | 11,5
7,93
45% | 19,2
9,89
95% | 12,5
15,5
-19% | 13,3
12,5
6,1% | 8,91
12,5
-29% | 10,00
8,23
21% | 21,9
8,00
173% | 199
81,1
145% | 19,3
25,5
-24% | 10,7
15,0
-29% |
11,1
|
15,3
|
21,8
|
36,4
|
49,0
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -145
-128
-13% | -152
-154
1,0% | -167
-146
-14% | -199
-164
-21% | -206
-197
-4,6% | -225
-201
-12% | -199
-192
-3,6% | -21,4
28,4
-175% | -185
-215
14% | -199
-201
0,91% |
-206
|
-205
|
-198
|
-185
|
-172
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -150
-153
1,8% | -157
-156
-0,62% | -171
-155
-10% | -203
-173
-17% | -210
-204
-3,3% | -231
-220
-4,6% | -203
-232
12% | -25,9
-126
79% | -190
-195
2,7% | -204
-207
1,4% |
-206
|
-205
|
-200
|
-191
|
-172
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -145
-155
6,2% | -149
-153
3,0% | -164
-150
-9,4% | -196
-169
-16% | -206
-199
-3,9% | -223
-215
-4,0% | -203
-229
12% | -21,5
-126
83% | -194
-189
-2,8% | -200
-202
1,3% |
-205
|
-206
|
-202
|
-201
|
-186
|
Net income
M $ |
Released
Forecast
Spread | -145
-155
6,4% | -149
-154
3,0% | -164
-150
-9,4% | -196
-169
-16% | -206
-198
-3,8% | -223
-215
-3,7% | -203
-229
11% | -21,5
-117
82% | -195
-191
-2,0% | -200
-202
1,2% |
-207
|
-207
|
-203
|
-200
|
-186
|
EPS
$ |
Released
Forecast
Spread | -2,73
-2,86
4,7% | -2,72
-2,84
4,3% | -2,99
-2,83
-5,8% | -3,55
-3,07
-16% | -3,73
-3,54
-5,4% | -4,04
-3,79
-6,7% | -3,64
-4,05
10% | -0,36
-2,52
86% | -2,94
-3,02
2,5% | -3,01
-2,96
-1,7% |
-3,05
|
-3,03
|
-2,94
|
-2,85
|
-2,62
| | Announcement Date | 11/01/2018 | 02/21/2019 | 05/02/2019 | 08/01/2019 | 10/31/2019 | 02/18/2020 | 05/11/2020 | 08/05/2020 | 11/04/2020 | 02/23/2021 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
